Marubeni Pharmaceuticals Corporation has commenced operations with Marubeni Corporation and Sumitomo Pharma Co., Ltd. as shareholders.
【About Marubeni Pharmaceuticals】
With a mission to “contribute to a world where people can live every day with a smile,” we are engaged in the sale of pharmaceuticals in China and Southeast Asia, a business inherited from Sumitomo Pharma Co., Ltd.
We define “providing the medicines, information, and value that are needed in each region, regardless of whether they are new or old” as value innovation, and we aim to continue growing as a value innovator in order to achieve our mission.
【Company Profile】
|
Name |
Marubeni Pharmaceuticals Corporation |
|
Address |
Nippon Life Nihonbashi Building 4F 2-13-12 Nihonbashi, Chuo-ku, Tokyo 103-0027 |
|
Business |
Manufacturing and sales of pharmaceuticals and others |
|
Establishment |
May 13, 2025 |
|
Capitalization |
115million yen |
|
Representative |
Representative Director, Chairman & CEO Yusuke Yamamoto |
